BWFA
BIIB icon

Baltimore-Washington Financial Advisors’s Biogen BIIB Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30
Closed -$8K – 105
2015
Q3 		$8K Buy
+30
New +$9.91K ﹤0.01% 207

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baltimore-Washington Financial Advisors's BIIB Position: Q4 2015 in Review

Baltimore-Washington Financial Advisors sold out of Biogen (BIIB) in Q4 2015, closing a stake of 30 shares — an estimated $8K sold.

Baltimore-Washington Financial Advisors first reported a position in BIIB in Q3 2015 and held it in 1 quarter. The position peaked at $8K in Q3 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Baltimore-Washington Financial Advisors reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 30 Biogen shares in Q4 2015, an estimated $8K.
  • Baltimore-Washington Financial Advisors first reported a position in Biogen in Q3 2015 and held it in 1 quarter.
  • Baltimore-Washington Financial Advisors's Biogen position peaked at $8K in Q3 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.